Principal Securities’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-593
Closed -$16.7K 3356
2025
Q3
$16.7K Buy
593
+4
+0.7% +$121 ﹤0.01% 2486
2025
Q2
$21.7K Buy
589
+95
+19% +$3.28K ﹤0.01% 2270
2025
Q1
$23K Hold
494
﹤0.01% 2126
2024
Q4
$23K Buy
494
+86
+21% +$3.89K ﹤0.01% 2121
2024
Q3
$18.4K Sell
408
-395
-49% -$18.8K ﹤0.01% 2156
2024
Q2
$39.6K Buy
803
+231
+40% +$9.42K ﹤0.01% 1730
2024
Q1
$19.6K Buy
572
+68
+13% +$2.45K ﹤0.01% 2013
2023
Q4
$18.6K Buy
+504
New +$11.7K ﹤0.01% 1966

Other funds holding TWST

Principal Securities's TWST Position: Q4 2025 in Review

Principal Securities sold out of Twist Bioscience (TWST) in Q4 2025, closing a stake of 593 shares — an estimated $16.7K sold.

Principal Securities first reported a position in TWST in Q4 2023 and held it in 8 quarters. The position peaked at $39.6K in Q2 2024. 243 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

  • Principal Securities reported no remaining Twist Bioscience position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 593 Twist Bioscience shares in Q4 2025, an estimated $16.7K.
  • Principal Securities first reported a position in Twist Bioscience in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Twist Bioscience position peaked at $39.6K in Q2 2024.
  • 243 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.